share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  06/28 20:37

牛牛AI助理已提取核心訊息

On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
2024年6月27日,Safety Shot公司與一位認可的投資者簽訂了一份證券購買協議,以每股1.06美元的價格出售943,396股,與當日的收盤價相匹配,不涉及任何折扣或佣金。該交易結果爲公司帶來了大約100萬美元的淨收益。值得注意的是,該投資者與該公司總裁Jordan Schur有着密切的關係,後者擁有該投資實體的15%的股份,並擁有家庭成員也是股東。此次投資是繼2024年4月該團隊投資500萬美元后的又一次投資。這些股票是通過定向增發的方式發行的,不需要事先進行登記,僅依靠登記豁免,公司還發布了一份新聞稿,詳細說明了投資情況,並強調了總裁對公司的創業板和產品創新的信懇智能。Safety Shot公司是一家健康和膳食補充劑公司,以開發一種有助於代謝血液酒精含量的專利產品而聞名。
2024年6月27日,Safety Shot公司與一位認可的投資者簽訂了一份證券購買協議,以每股1.06美元的價格出售943,396股,與當日的收盤價相匹配,不涉及任何折扣或佣金。該交易結果爲公司帶來了大約100萬美元的淨收益。值得注意的是,該投資者與該公司總裁Jordan Schur有着密切的關係,後者擁有該投資實體的15%的股份,並擁有家庭成員也是股東。此次投資是繼2024年4月該團隊投資500萬美元后的又一次投資。這些股票是通過定向增發的方式發行的,不需要事先進行登記,僅依靠登記豁免,公司還發布了一份新聞稿,詳細說明了投資情況,並強調了總裁對公司的創業板和產品創新的信懇智能。Safety Shot公司是一家健康和膳食補充劑公司,以開發一種有助於代謝血液酒精含量的專利產品而聞名。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。